These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 6929361

  • 1. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K, Hirano S, Hori S.
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [Abstract] [Full Text] [Related]

  • 2. [General pharmacology of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic].
    Tone H, Kiyosaki T, Nishimori T, Kobayashi F, Nishimura K, Morino H, Tsuchiyama M.
    Jpn J Antibiot; 1986 Feb; 39(2):526-46. PubMed ID: 3712756
    [Abstract] [Full Text] [Related]

  • 3. [General pharmacological studies on pepleomycin sulfate (NK 631) (author's transl)].
    Ishii Y, Furuta Y, Adachi K, Fujii Y, Nakamura K, Itoh S, Saitoh K, Terada M, Watanabe H.
    Jpn J Antibiot; 1978 Dec; 31(12):910-21. PubMed ID: 83413
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T, Kojima H, Tanaka M, Aibara S, Hirohashi M, Kasai Y, Tsubokawa M, Watanabe K, Akashi A.
    Arzneimittelforschung; 1981 Dec; 31(4):707-15. PubMed ID: 6113834
    [Abstract] [Full Text] [Related]

  • 5. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (3). General pharmacological actions (author's transl)].
    Sato M, Ishizuka Y, Tanizawa H, Fukuda T, Yuizono T.
    Nihon Yakurigaku Zasshi; 1979 Apr 20; 75(3):291-307. PubMed ID: 317064
    [Abstract] [Full Text] [Related]

  • 7. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T.
    Arzneimittelforschung; 1996 Jul 20; 46(7):727-39. PubMed ID: 8842346
    [Abstract] [Full Text] [Related]

  • 8. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985 Jul 20; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984 Jul 20; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 10. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec 20; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 11. [General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)].
    Takai A, Hirai S, Watanabe I, Hiraiwa T, Abe N, Omori M, Muroda T, Nakajima S, Nakada Y, Tanada K, Senda N, Tanaka K, Makino H.
    Jpn J Antibiot; 1980 Oct 20; 33(10):994-1018. PubMed ID: 6451724
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacological effects of CM6912 and its main metabolites].
    Morishita H, Kushiku K, Furukawa T, Yamaki Y, Izawa M, Shibazaki Y, Shibata U.
    Nihon Yakurigaku Zasshi; 1985 Jul 20; 86(1):71-85. PubMed ID: 4043871
    [Abstract] [Full Text] [Related]

  • 13. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K, Fujita S, Umezato M, Hosoki E, Toba Y, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct 20; 42(10):1200-11. PubMed ID: 1472141
    [Abstract] [Full Text] [Related]

  • 14. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K, Hiraiwa T, Terashima N, Arai H, Ono S, Hashiba K, Maekawa M, Kitamura K, Nakada Y, Mori Y.
    Jpn J Antibiot; 1995 May 20; 48(5):706-32. PubMed ID: 7637205
    [Abstract] [Full Text] [Related]

  • 15. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct 20; 42(10):1212-22. PubMed ID: 1335257
    [Abstract] [Full Text] [Related]

  • 16. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K, Kimura T, Saeki I, Tabata R, Yamazaki S, Eguchi I, Hanazuka M, Horii D, Munt PL, Davis AS.
    Arzneimittelforschung; 1994 Jun 20; 44(6):715-26. PubMed ID: 8053970
    [Abstract] [Full Text] [Related]

  • 17. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K, Kasai Y, Usui C, Takahashi M, Hirohashi M, Tamura K, Takayama S.
    Arzneimittelforschung; 1992 Mar 20; 43(3A):408-18. PubMed ID: 1622443
    [Abstract] [Full Text] [Related]

  • 18. [General pharmacology of T-1982, a new cephamycin antibiotic].
    Takai A, Hirai S, Watanabe I, Hiraiwa T, Abe N, Arai H, Omori M, Tanada K, Senda N, Hashiba K, Matsukura K, Takata K, Okami H.
    Jpn J Antibiot; 1982 Sep 20; 35(9):2139-54. PubMed ID: 7143714
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacological studies of cefatrizine (S-640P) (author's transl)].
    Matsuzaki M, Onodera K, Okazaki I, Nakajima A, Kishimoto K.
    Jpn J Antibiot; 1976 Jan 20; 29(1):107-21. PubMed ID: 1263334
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmacological action of [ethyl p(6-guanidinohexanoyloxy)benzoate] methanesulfonate (FOY)].
    Okegawa T, Aishita H, Akimoto A, Makita T, Nakai H.
    Nihon Yakurigaku Zasshi; 1975 Jan 20; 71(1):71-87. PubMed ID: 239887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.